ESMO 2016 Congress

Oncology Meeting Resources

07 Oct - 11 Oct 2016, Copenhagen, Denmark

ESMO-Congress-2016-square

The annual ESMO congress is the premier scientific platform to present your oncology research and as such, the ultimate learning experience for congress attendees. Find the abstracts, posters, PDF presentation and webcasts from ESMO 2016 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Special Sessions and Tracks

Useful links





Format available

https://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/T-cell-therapy-For-whom-and-when2

Date: 07 Oct 2016
Presenter: Inge-Marie Svane
Resources: Presentation, Webcast
Topic: Immunotherapy

https://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/Back-to-the-basics

Date: 07 Oct 2016
Presenter: Sjoerd van der Burg
Resources: Presentation, Webcast
Topics: Cancer Biology, Immunotherapy, Basic Scientific Principles, Therapy

https://oncologypro.esmo.org/Meeting-Resour...-checkpoints-Do-we-really-know-how-they-work

Date: 07 Oct 2016
Presenter: Ignacio Melero
Resources: Presentation, Webcast
Topics: Immunotherapy, Therapy

https://oncologypro.esmo.org/Meeting-Resour...2016/ESMO-Lifetime-Achievement-Award-lecture

Date: 07 Oct 2016
Presenter: Richard Peto
Resources: Presentation

https://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/Welcome-to-Copenhagen

Date: 07 Oct 2016
Presenter: Ulrik Lassen
Resources: Webcast

https://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/ESMO-2016-Scientific-address

Date: 07 Oct 2016
Presenter: Andrés Cervantes
Resources: Presentation

https://oncologypro.esmo.org/Meeting-Resour...the-clinical-benefit-of-antineoplastic-drugs

Date: 07 Oct 2016
Presenter: Alberto Sobrero
Resources: Presentation

https://oncologypro.esmo.org/Meeting-Resour...urvival-OS-in-localized-prostate-cancer-CaP2

BackgroundAdvances in the treatment of localized CaP have led to decreased recurrences and improved OS. The Intermediate Clinical Endpoints in CaP (ICECaP) Working Group is conducting meta-analysis of...

Date: 07 Oct 2016
Presenter: Wanling Xie
Resources: Abstract
Topic: Prostate Cancer

https://oncologypro.esmo.org/Meeting-Resour...ation-associated-ovarian-cancer-gBRCAm-OvCa2

BackgroundCheckpoint kinases 1 and 2 (CHK1/2) are the primary cell cycle regulators in tumors with p53 dysfunction, such as HGSOC. The second-generation CHK1/2 inhibitor, LY2606368 showed preliminary...

Date: 07 Oct 2016
Presenter: Jung-Min Lee
Resources: Abstract
Topics: Clinical Research, Ovarian Cancer

https://oncologypro.esmo.org/Meeting-Resour...rent-epithelial-ovarian-cancer-CRUKE-12-0522

BackgroundThere is a need for more therapy options in recurrent epithelial ovarian cancer (EOC). Androgens bind to the androgen receptor (AR) which is commonly expressed in EOC.

Date: 07 Oct 2016
Presenter: Susana Banerjee
Resources: Abstract, Presentation, Webcast
Topics: Anticancer Agents, Ovarian Cancer